Wang Shaoting, Zuo Anna, Jiang Weiqiang, Xie Jiarun, Lin Haoyu, Sun Wei, Zhao Min, Xia Jinjin, Shao Junqiao, Zhao Xiaoshan, Liang Donghui, Yang Aicheng, Sun Jia, Wang Ming
School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Front Med (Lausanne). 2022 Feb 3;8:807694. doi: 10.3389/fmed.2021.807694. eCollection 2021.
Diabetic kidney disease (DKD) is one of the most serious complications of diabetic patients. Advanced glycation end products (AGEs) induce epithelial-mesenchymal transformation (EMT) of renal tubular epithelial cells (HK-2), resulting in renal tubulointerstitial fibrosis. However, the underlying epigenetic mechanisms remain to be further investigated. In this work, we investigated the functional role of JMJD1A involved in DKD progression. The molecular mechanism study was performed in AGEs-induced HK-2 cells by gene expression analysis, RNA sequencing (RNA-seq), and JMJD1A lentiviral knockdown and overexpression particle transfection. The results showed that AGEs could upregulate JMJD1A, and the expressions of related fibrotic factor were also increased. At the same time, in the DKD animal model induced by unilateral nephrectomy plus streptozotocin (STZ), IHC immunohistochemical staining showed that compared with the control group, the expressions of JMJD1A, FN, and COL1 in the model group were all increased, masson staining results also show that the model group has typical fibrotic changes. This is consistent with the results of our experiments. In order to determine the downstream pathway, we screened out JMJD1A downstream transcription factors by RNA-seq. Further analysis showed that JMJD1A overexpression could accelerate the progression of AGEs-induced renal fibrosis by reducing the expression of NR4A1 in HK-2 cells. Meanwhile, NR4A1 inhibitor can promote the expression of fibrosis-related factors such as VIM, a-SMA in HK-2 cells, and aggravate the process of fibrosis. Taken together, JMJD1A/NR4A1 signaling can regulate the procession of renal tubular epithelial interstitial fibrosis induced by AGEs in HK-2.
糖尿病肾病(DKD)是糖尿病患者最严重的并发症之一。晚期糖基化终末产物(AGEs)诱导肾小管上皮细胞(HK-2)发生上皮-间质转化(EMT),导致肾小管间质纤维化。然而,其潜在的表观遗传机制仍有待进一步研究。在本研究中,我们探究了JMJD1A在DKD进展中的作用。通过基因表达分析、RNA测序(RNA-seq)以及JMJD1A慢病毒敲低和过表达颗粒转染,在AGEs诱导的HK-2细胞中进行分子机制研究。结果显示,AGEs可上调JMJD1A,相关纤维化因子的表达也增加。同时,在单侧肾切除加链脲佐菌素(STZ)诱导的DKD动物模型中,免疫组化(IHC)染色显示,与对照组相比,模型组中JMJD1A、纤连蛋白(FN)和Ⅰ型胶原蛋白(COL1)的表达均增加,Masson染色结果也表明模型组有典型的纤维化改变。这与我们的实验结果一致。为了确定下游途径,我们通过RNA-seq筛选出JMJD1A下游转录因子。进一步分析表明,JMJD1A过表达可通过降低HK-2细胞中NR4A1的表达加速AGEs诱导的肾纤维化进程。同时,NR4A1抑制剂可促进HK-2细胞中波形蛋白(VIM)、α-平滑肌肌动蛋白(α-SMA)等纤维化相关因子的表达,并加重纤维化进程。综上所述,JMJD1A/NR4A1信号通路可调节AGEs诱导的HK-2肾小管上皮间质纤维化进程。